Abstract
Histiocytic sarcoma (HS) is a rare malignant neoplasm, with morphological and immunophenotypic characteristics similar to mature histiocytes, representing less than 1% of all hematological malignancies. HS can be associated with lymphomas, myelodysplasia, and some leukemias. Its clinical presentation varies from being localized to presenting systemic compromise. We present the clinical case of an 11-year-old boy with a 6-year OLD history of Acute Lymphoblastic Leukemia B, in complete continuous remission (CCR). Two years after finishing his treatment, the patient presents symptoms of abdominal pain and vomiting, intermittent fever. Abomino-pelvic CT with expansive mass at the mesenteric level. With an anatomopathological diagnosis by biopsy of histiocytic sarcoma, he performed 2 cycles of preoperative chemotherapy, followed by a right hemicolectomy with complete resection. Due to compromised microscopic margins and infiltrated lymph nodes, it was decided to continue chemotherapy, completing two more cycles. Seven months after the diagnosis, 2 metabolically active retroperitoneal lymphadenopathies were confirmed by PET-CT and they were completely resected. With PET-CT control 9 months after the last surgery, there was no evidence of hyper-uptake lymphadenopathy. He currently remains in CCR 2 years after diagnosis.
References
2. Hornick JL, Jaffe ES, Fletcher Ch. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy.Am J Surg Pathol. 2004 Sep; 28 (9):1133-44. doi: 10.1097/01.pas.0000131541.95394.23.
3. Kommalapati A, Harsha Tella S, Predictors of survival, treatment patterns, and outcomes in histiocytic sarcoma. LEUKEMIA & LYMPHOMA Volume 60, 2019. https://doi.org/10.1080/10428194.2018.1492128
4. Tocut M, Vaknine H, Potachenko P, y col. Histiocytic Sarcoma. Med Assoc J. 2020 Oct; 22(10):645-647.PMID: 33070490
5. Hung YP, Lovitch SB, Qian X.Histiocytic sarcoma: New insights into FNA cytomorphology and molecular characteristics. Cancer Cytopathol. 2017 Aug; 125(8):604-614. doi: 10.1002/cncy.21851. Epub 2017 Apr 24. PMID: 28805986
6. Ansari J, Naqash A, Munker R. y col. Histiocytic Sarcoma as a Secondary Malignancy: Pathobiology, Diagnosis, and Treatment. Eur J Haematol. 2016 Jul; 97 (1):9-16. doi: 10.1111/ejh.12755. Epub 2016 Apr 8.
7. Go H, Jeon YK, Huh J y col Frequent detection of BRAF (V600E) mutations in histiocytic and dendritic cell neoplasms. Histopathology. 2014 Aug; 65(2):261-72. doi: 10.1111/his.12416. Epub 2014 May 12. PMID: 24720374
8. Abu-Sanad A, Warsi A, Michel RP, Nahal A, y col. Long-term remission after autologous stem-cell transplantation for relapsed histiocytic sarcoma. Curr Oncol. 2012; 19:e289-91.
All material published in the journal HEMATOLOGÍA (electronic and print version) is transferred to the Argentinean Society of Hematology. In accordance with the copyright Act (Act 11 723), a copyright transfer form will be sent to the authors of approved works, which has to be signed by all the authors before its publication. Authors should keep a copy of the original since the journal is not responsible for damages or losses of the material that was submitted. Authors should send an electronic version to the email: revista@sah.org.ar
